6 Results for "

Bleomycin (BLM)

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Bleomycin (BLM)" in MCE Product Catalog:

Cat. No.: HY-176194
Target:  

Collagen c-Fms PDGFR Src

Research Areas:  

Inflammation/Immunology

Antifibrotic agent 1 is an orally active anti-idiopathic pulmonary fibrosis (IPF) agent. Antifibrotic agent 1 effectively attenuates IPF-related processes, including TGF-β induced EMT and FMT processes, as well as pro-fibrotic M2 polarization. Antifibrotic agent 1 selectively inhibits CSF-1R, PDGFR-α and Src family kinases (SFKs), while sparing VEGFRs, FGFRs and Abl to minimize off-target toxicity. Antifibrotic agent 1 has potent anti-fibrotic activity in Bleomycin (BLM) (HY-108345)-induced pulmonary fibrosis mice model .
loading...
    loading...
Cat. No.: HY-173483
CAS No.: 2940248-11-1
ATX inhibitor 26 is an Autotaxin (ATX) inhibitor with an IC50 of 57 nM in human plasma. ATX inhibitor 26 inhibits cell migration and collagen gel contraction. ATX inhibitor 26 has significant anti-fibrotic effects, reducing collagen deposition in a Bleomycin (BLM) (HY-108345)-induced pulmonary fibrosis model .
loading...
    loading...
Cat. No.: HY-175277
Research Areas:  

Inflammation/Immunology

PIM1-IN-8 is a PIM1/p65 pathway inhibitor. PIM1-IN-8 suppresses the expression of α-SMA and collagen I in activated fibroblasts and blocks TGF-β induced migration. PIM1-IN-8 alleviates pulmonary fibrosis in a Bleomycin (BLM) (HY-17565A)-induced pulmonary fibrosis mice model. PIM1-IN-8 can be used for the study of idiopathic pulmonary fibrosis (IPF) .
loading...
    loading...
Cat. No.: HY-P76170
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Bleomycin hydrolase; BH; BLM hydrolase; BMH
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700626
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Bleomycin hydrolase; BH; BLM hydrolase; BMH
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-179645
Phosphodiesterase-IN-5 is a potent, orally active and selective phosphodiesterase 10A (PDE10A) inhibitor with an IC50 of 6.2 nM. Phosphodiesterase-IN-5 shows >1612-fold selectivity over other PDEs. Phosphodiesterase-IN-5 exhibits potent antifibrotic efficacy in a Bleomycin (BLM) (HY-108345)-induced murine model of pulmonary fibrosis (PF) by blocking myofibroblast differentiation via the cAMP/PKA/CREB signaling pathway. Phosphodiesterase-IN-5 can be used for the research of PF .
loading...
    loading...